Bengaluru-based CRDMO-in-transition offering contract research, development and manufacturing services to pharma, biopharma, agro-chemical, medical-device and specialty-chemical customers in India and abroad.
Price
Market Cap
Sector
Healthcare
Rank
| Line item | FY22 | FY23 | FY24 | FY25 | FY26 | FY26 |
|---|---|---|---|---|---|---|
| LiabilitiesEquity Capital | 10 | 21 | 35 | 35 | 35 | 35 |
| Reserves | -2 | 1 | 37 | 24 | 17 | 12 |
| Borrowings | 0 | 0 | 9 | 39 | 20 | 23 |
| Other Liabilities | 2 | 2 | 11 | 22 | 26 | 16 |
| Total Liabilities | 11 | 25 | 91 | 120 | 98 | 87 |
| AssetsFixed Assets | 0 | 0 | 63 | 77 | 55 | 54 |
| CWIP | 0 | 2 | 7 | 5 | 3 | 6 |
| Investments | 0 | 3 | 0 | 0 | 0 | 0 |
| Other Assets | 11 | 19 | 21 | 39 | 41 | 27 |
| Total Assets | 11 | 25 | 91 | 120 | 98 | 87 |
| Line item | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| ActivitiesCash from Operating | 0 | -4 | -11 | -14 | -4 |
| Cash from Investing | 0 | -5 | -75 | -12 | 23 |
| Cash from Financing | 0 | 21 | 78 | 23 | -20 |
| SummaryCapital Expenditure | — | — | — | — | — |
| Free Cash Flow | 0 | -6 | -33 | -26 | 11 |
| FCF Margin | — | — | — | — | — |
For capital-heavy businesses (telecom, power, heavy manufacturing) reported profit ignores the cash needed just to stand still. We'd systematically overvalue it, so we don't show a number.
524572 · CAPITAL_INTENSIVE
Guides on how to read this kind of business and the numbers that matter.